Syntimmune is Biotechnology in United States that focus on platform leverages business. Founded in 2013. They cover business area such as operator, differentiated drug candidate, autoimmune disease, FcRn biology, transformative therapy, patient, physician, to get humanize monoclonal antibody, IgG, treatment, a number.
2013
( 11 years old in 2024 )
Platform Leverages
-
116 Huntington Avenue
Suite 301
Boston, MA 02116
United States
Private
operatordifferentiated drug candidateautoimmune diseaseFcRn biologytransformative therapypatientphysicianto get humanize monoclonal antibodyIgGtreatmenta number
* We use standard office opening hours in near Syntimmune's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Syntimmune is Biotechnology business from United States that founded in 2013 (11 years old in 2024), Syntimmune business is focusing on Platform Leverages.
Syntimmune headquarter office and corporate office address is located in 116 Huntington Avenue Suite 301 Boston, MA 02116 United States.
Syntimmune was founded in United States.
In 2024, Syntimmune is currently focus on platform leverages sector.
Above is snippet of Google Trends for "platform leverages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Syntimmune, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
